DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 884 filers reported holding DANAHER CORPORATION in Q4 2013. The put-call ratio across all filers is 0.40 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62,001,927 | -5.7% | 249,907 | -8.7% | 2.16% | -3.2% |
Q2 2023 | $65,715,120 | -1.3% | 273,813 | +3.6% | 2.23% | -19.4% |
Q1 2023 | $66,605,351 | -8.4% | 264,265 | -3.5% | 2.77% | -22.1% |
Q4 2022 | $72,711,544 | -99.9% | 273,949 | -1.5% | 3.55% | +0.5% |
Q3 2022 | $71,815,210,000 | +101331.0% | 278,041 | -0.4% | 3.54% | +8.0% |
Q2 2022 | $70,802,000 | -12.9% | 279,277 | +0.8% | 3.28% | +4.9% |
Q1 2022 | $81,285,000 | +9.5% | 277,111 | +22.8% | 3.12% | +23.3% |
Q4 2021 | $74,218,000 | +6.9% | 225,580 | -1.0% | 2.53% | -1.6% |
Q3 2021 | $69,398,000 | +14.0% | 227,953 | +0.4% | 2.57% | +21.0% |
Q2 2021 | $60,901,000 | +18.8% | 226,938 | -0.3% | 2.13% | +3.2% |
Q1 2021 | $51,242,000 | +7.7% | 227,663 | +6.3% | 2.06% | -11.8% |
Q4 2020 | $47,593,000 | -5.2% | 214,247 | -8.1% | 2.34% | -17.0% |
Q3 2020 | $50,181,000 | +27.5% | 233,040 | +4.7% | 2.82% | +2.3% |
Q2 2020 | $39,369,000 | +39.8% | 222,640 | +9.4% | 2.75% | +7.6% |
Q1 2020 | $28,160,000 | +292.5% | 203,455 | +335.2% | 2.56% | +142.1% |
Q4 2019 | $7,175,000 | +45.3% | 46,747 | +36.7% | 1.06% | +25.4% |
Q3 2019 | $4,939,000 | +5.9% | 34,196 | +4.8% | 0.84% | +4.9% |
Q2 2019 | $4,663,000 | +9.8% | 32,627 | +1.4% | 0.80% | +10.7% |
Q1 2019 | $4,247,000 | -31.5% | 32,173 | -46.5% | 0.73% | -42.6% |
Q4 2018 | $6,199,000 | -19.3% | 60,112 | -15.0% | 1.26% | +16.8% |
Q3 2018 | $7,683,000 | +11.9% | 70,710 | +1.7% | 1.08% | +2.1% |
Q2 2018 | $6,864,000 | -1.8% | 69,556 | -2.6% | 1.06% | -8.2% |
Q1 2018 | $6,993,000 | +4.0% | 71,421 | -1.4% | 1.16% | +21.6% |
Q4 2017 | $6,722,000 | +0.4% | 72,416 | -7.2% | 0.95% | -0.9% |
Q3 2017 | $6,697,000 | -40.7% | 78,071 | -41.6% | 0.96% | -39.7% |
Q2 2017 | $11,289,000 | +1.0% | 133,766 | +2.4% | 1.59% | -0.6% |
Q1 2017 | $11,176,000 | +8.7% | 130,668 | -1.1% | 1.60% | -6.9% |
Q4 2016 | $10,280,000 | +6.1% | 132,061 | +6.9% | 1.72% | -3.3% |
Q3 2016 | $9,687,000 | -21.1% | 123,578 | +1.7% | 1.78% | -30.4% |
Q2 2016 | $12,278,000 | -8.6% | 121,564 | -14.2% | 2.55% | -5.0% |
Q1 2016 | $13,437,000 | +25.4% | 141,651 | +22.8% | 2.69% | +26.9% |
Q4 2015 | $10,716,000 | +24.9% | 115,374 | +14.5% | 2.12% | +6.4% |
Q3 2015 | $8,582,000 | +52.9% | 100,720 | +52.4% | 1.99% | +47.8% |
Q1 2015 | $5,611,000 | +57.1% | 66,094 | +58.6% | 1.34% | +47.6% |
Q4 2014 | $3,572,000 | +11.2% | 41,675 | -1.5% | 0.91% | +5.1% |
Q3 2014 | $3,213,000 | -4.0% | 42,290 | -0.5% | 0.87% | -15.9% |
Q2 2014 | $3,346,000 | +16.1% | 42,500 | +10.6% | 1.03% | +2.9% |
Q1 2014 | $2,881,000 | +1.7% | 38,410 | +4.7% | 1.00% | -9.9% |
Q4 2013 | $2,833,000 | – | 36,700 | – | 1.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
Third Point | 2,700,000 | $697,383,000 | 12.60% |
Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |